Table 3.
Wild-type
|
TNCKO
|
|||
---|---|---|---|---|
Saline Vehicle | AT II | Saline Vehicle | AT II | |
Number | 5 | 9 | 5 | 9 |
Heart rate, beats/min | 440 ± 28 | 426 ± 36 | 435 ± 18 | 449 ± 55 |
EF, % | 66.6 ± 1.9 | 52 ± 2.5† | 67.8 ± 1.6 | 42.8 ± 7.3*† |
FS, % | 36.1 ± 1.5 | 26.3 ± 1.6† | 37.1 ± 1 | 20.9 ± 4*† |
LVIDd, mm | 3.57 ± 0.12 | 3.96 ± 0.23† | 3.5 ± 0.28 | 4.08 ± 0.33*† |
LVIDs, mm | 2.28 ± 0.04 | 2.92 ± 0.16† | 2.2 ± 0.18 | 3.23 ± 0.38*† |
PWTd, mm | 0.6 ± 0.07 | 0.77 ± 0.03† | 0.64 ± 0.03 | 0.85 ± 0.08*† |
PWTs, mm | 0.92 ± 0.07 | 1.05 ± 0.04† | 0.88 ± 0.07 | 1.15 ± 0.09*† |
HW-BW, mg/g | 4.06 ± 0.24 | 4.78 ± 0.4† | 4.02 ± 0.21 | 5.26 ± 0.46*† |
Values are mean ± SD.
Significant difference between TNCKO and wild-type mice.
Significant difference between angiotensin (AT) II treatment and saline control group.
Other abbreviations as in Table 1.